Literature DB >> 6376529

Plasma "big" and "big-big" growth hormone (GH) in man: an oligomeric series composed of structurally diverse GH monomers.

M W Stolar, K Amburn, G Baumann.   

Abstract

Human GH (hGH) immunoreactivity in plasma can be separated into three species of different molecular size by gel filtration (little, big, and big-big hGH). In contrast to pituitary high mol wt GH forms, the molecular nature of the big hGH forms in blood is not known. Therefore, we purified these hGH size isomers from the plasma of L-dopa-stimulated normal subjects and acromegalic patients. Plasma was chromatographed on Sephadex G-100, and fractions containing big-big, big, and little hGH were generated. hGH was extracted and concentrated from these fractions by immunoadsorbent chromatography and analyzed by polyacrylamide gel electrophoresis (PAGE), sodium dodecyl sulfate-PAGE, and isoelectric focusing. The resulting gel profiles indicated that the majority (70%) of big and big-big hGH was converted to little hGH during extraction and storage. The remainder migrated as distinct species with mol wt of approximately 45, 62, 80, and 110 K in sodium dodecyl sulfate-PAGE. These forms could be converted almost completely to little hGH by sulfhydryl reduction. Little hGH (both native and converted from big forms) was composed of several monomeric hGH species, namely the 22 K form (principal), the 20 K variant, and at least one acidic form. All hGH size isomers contained the same monomeric building blocks, although in somewhat different proportions. Big hGH, e.g. was particularly rich in 20K. No abnormal or previously unrecognized hGH forms were identified as components of big or big-big hGH. Binding of hGH to plasma proteins could not be demonstrated. We conclude that 1) plasma big and big-big hGH represent an oligomeric series composed of 22K (major), 20K, and one or more acidic hGH monomers, 2) the majority of these oligomers are noncovalently associated, with a smaller fraction consisting of monomers linked by disulfide bridges.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6376529     DOI: 10.1210/jcem-59-2-212

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Molecular heterogeneity of human GH: from basic research to clinical implications.

Authors:  C L Boguszewski
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

2.  Immunoreactive growth hormone production by human lymphocyte cell lines.

Authors:  T L Kao; S C Supowit; E A Thompson; W J Meyer
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

Review 3.  Growth hormone deficiency: etiology, pathology, science and diagnosis.

Authors:  S M De Muinck Keizer-Schrama
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

4.  Serum and liver cytosolic growth-hormone-binding proteins are antigenically identical with liver membrane 'receptor' types 1 and 2.

Authors:  R Barnard; M J Waters
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

5.  Plasma clearance of heterogeneous growth hormone components in the rat: effects of diabetes and starvation.

Authors:  T Jolin; C González
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

6.  Urinary growth hormone excretion rates in normal and acromegalic man: a critical appraisal of its potential clinical utility.

Authors:  L M Winer; M A Shaw; G Baumann
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

7.  Responses of growth hormone aggregates to different intermittent exercise intensities.

Authors:  Martyn R Rubin; William J Kraemer; Robert R Kraemer; Robert J Durand; Edmund O Acevedo; Lisa G Johnson; V D Castracane; Timothy P Scheett; Duncan N French; Jeff S Volek
Journal:  Eur J Appl Physiol       Date:  2003-01-31       Impact factor: 3.078

8.  Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.

Authors:  John F Langenheim; Dunyong Tan; Ameae M Walker; Wen Y Chen
Journal:  Mol Endocrinol       Date:  2005-11-03

9.  Identification and characterization of specific binding proteins for growth hormone in normal human sera.

Authors:  A C Herington; S Ymer; J Stevenson
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

10.  Growth Hormone and Insulin-like Growth Factor-I Molecular Weight Isoform Responses to Resistance Exercise Are Sex-Dependent.

Authors:  Joseph R Pierce; Brian J Martin; Kevin R Rarick; Joseph A Alemany; Jeffery S Staab; William J Kraemer; Wesley C Hymer; Bradley C Nindl
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.